Publication Name	World Journal of Clinical Cases
Manuscript ID	84888
Country	China

Received	2023-03-31 14:02
Peer-Review Started	2023-03-31 14:04
First Decision by Editorial Office Director	2023-07-03 08:02
Return for Revision	2023-07-03 08:02
Revised	2023-07-17 15:52
Publication Fee Transferred
Second Decision by Editor	2023-07-25 02:57
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2023-07-25 07:08
Articles in Press	2023-07-25 07:08
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-08-03 11:42
Publish the Manuscript Online	2023-08-16 06:59

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Case Report
Article Title	Membranous nephropathy with systemic light-chain amyloidosis of remission after rituximab therapy: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Jiao Zhang, Xu Wang, Gu-Ming Zou, Jia-Yi Li and Wen-Ge Li
ORCID	Author(s) ORCID Number Jiao Zhang http://orcid.org/0000-0001-5210-6665 Wen-Ge Li http://orcid.org/0000-0002-4749-1009
Funding Agency and Grant Number
Corresponding Author	Wen-Ge Li, MD, PhD, Professor, Department of Nephrology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Beijing 100029, China. wenge_lee2002@126.com
Key Words	Amyloidosis; Membranous nephropathy; Phospholipase A2 receptors; Rituximab; Renal biopsy; Case report
Core Tip	We report a rare case of phospholipase A2 receptor-related membranous nephropathy complicated with primary systemic light-chain amyloidosis with only renal involvement. The patient achieved complete remission after receiving rituximab, glucocorticoids and CyBorD regimen chemotherapy. Additionally, we conducted a literature review to provide current evidence on early diagnosis and treatment of this disease.
Publish Date	2023-08-16 06:59
Citation	Zhang J, Wang X, Zou GM, Li JY, Li WG. Membranous nephropathy with systemic light-chain amyloidosis of remission after rituximab therapy: A case report. World J Clin Cases 2023; 11(23): 5538-5546
URL	https://www.wjgnet.com/2307-8960/full/v11/i23/5538.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i23.5538

Full Article (PDF)	WJCC-11-5538-with-cover.pdf
Full Article (Word)	WJCC-11-5538.docx
CARE Checklist–2016	84888-CARE-Checklist–2016-revision.pdf
Manuscript File	84888_Auto_Edited-LJH-JLW.docx
Answering Reviewers	84888-Answering reviewers.pdf
Audio Core Tip	84888-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	84888-Conflict-of-interest statement.pdf
Copyright License Agreement	84888-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	84888-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	84888-Language certificate.pdf
Peer-review Report	84888-Peer-review(s).pdf
Scientific Misconduct Check	84888-Bing-Liu JH-2.png
Scientific Misconduct Check	84888-CrossCheck.png
Scientific Editor Work List	84888-Scientific editor work list.pdf
CrossCheck Report	84888-CrossCheck report.pdf